zofenil comp 30 mg / 12.5 mg
menarini international o.l. s.a. - zofenoprilkalsium / hydroklortiazid - tablett, filmdrasjert - 30 mg / 12.5 mg
hypoloc 5 mg
menarini international o.l. s.a. - nebivololhydroklorid - tablett - 5 mg
migard 2.5 mg
menarini international o.l. s.a. - frovatriptan - tablett, filmdrasjert - 2.5 mg
alea 20 mg / 5 mg
menarini international o.l. sa - olmesartanmedoksomil / amlodipinbesilat - tablett, filmdrasjert - 20 mg / 5 mg
benetor 20 mg
menarini international o.l. s.a. - olmesartanmedoksomil - tablett, filmdrasjert - 20 mg
zofenil 30 mg
menarini international o.l. s.a. - zofenoprilkalsium - tablett, filmdrasjert - 30 mg
zilas 20 mg
menarini international o.l. sa - bilastin - tablett - 20 mg
alea comp
menarini international o.l. sa - olmesartanmedoksomil / amlodipinbesilat / hydroklortiazid - tablett, filmdrasjert - 20 mg / 5 mg / 12.5 mg
adenuric 80 mg
2care4 aps - febuksostat - tablett, filmdrasjert - 80 mg
quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - fellesskapsmessige infeksjoner - antibakterielle midler for systemisk bruk, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.